<p>Fortrea（纳斯达克代码：FTRE - 获取免费报告）在 Truist Financial 发布的一份报告中被股票研究人员从 “持有” 评级上调至 “强力买入” 评级，Zacks.com 报道。</p>
<p>其他研究分析师也对该股票发布了研究报告。瑞穗证券在 12 月 18 日的研究报告中将 Fortrea 的目标价格从 11.00 美元上调至 13.00 美元，并给予该股票 “中性” 评级。Zacks Research 在 10 月 20 日的报告中将 Fortrea 的评级从 “强力买入” 下调至 “持有”。巴克莱在 12 月 15 日的报告中为 Fortrea 设定了 15.00 美元的目标价格，并给予公司 “等权重” 评级。Evercore ISI 在周二为 Fortrea 设定了 25.00 美元的目标价格，并给予该股票 “跑赢大盘” 评级。最后，花旗集团在 12 月 11 日的研究报告中将 Fortrea 的评级从 “中性” 上调至 “买入”，并将该股票的目标价格从 12.00 美元上调至 21.00 美元。两位股票研究分析师给予该股票 “强力买入” 评级，三位给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，平均目标价格为 16.17 美元。</p>
<p><strong>获取我们关于 Fortrea 的最新研究报告</strong></p>
<h2>Fortrea 股价下跌 0.3%</h2>
<p>周四，Fortrea 股票开盘价为 17.44 美元。该股票的 50 日移动平均线为 14.06 美元，200 日移动平均线为 10.14 美元。公司的债务与股本比率为 1.81，速动比率为 1.00，流动比率为 1.00。该公司的市值为 16.1 亿美元，市盈率为-1.55，PEG 比率为 0.51，贝塔值为 1.59。Fortrea 的 52 周低点为 3.97 美元，52 周高点为 19.00 美元。</p>
<p>Fortrea（纳斯达克代码：FTRE - 获取免费报告）最后一次公布季度财报是在 11 月 5 日，报告显示该季度每股收益为 0.12 美元，低于市场共识预期的 0.16 美元（差额为 0.04 美元）。该季度的营业收入为 7.013 亿美元，而分析师预期为 6.4343 亿美元。Fortrea 的净利润率为-36.77%，股本回报率为 5.64%。作为一个整体，研究分析师预测 Fortrea 在当前年度的每股收益为 0.51 美元。</p>
<h2>机构投资者对 Fortrea 的看法</h2>
<p>对该股票的对冲基金最近进行了买入和卖出交易。Allworth Financial LP 在第二季度将其在 Fortrea 的持股比例提高了 6,802.4%。Allworth Financial LP 现在拥有 5,660 股该公司的股票，价值 28,000 美元，此前在该期间内又购买了 5,578 股。Nisa Investment Advisors LLC 在第三季度将其在 Fortrea 的持股提高了 214.3%。Nisa Investment Advisors LLC 现在拥有 3,341 股该公司的股票，价值 28,000 美元，此前在上个季度又收购了 2,278 股。Osaic Holdings Inc.在第二季度将其在 Fortrea 的持股提高了 74.3%。Osaic Holdings Inc.现在拥有 6,844 股该公司的股票，价值 38,000 美元，此前在上个季度又收购了 2,918 股。Tower Research Capital LLC TRC 在第二季度将其在 Fortrea 的持股提高了 137.0%。Tower Research Capital LLC TRC 现在拥有 8,713 股该公司的股票，价值 43,000 美元，此前在上个季度又收购了 5,036 股。最后，Ameritas Investment Partners Inc.在第二季度收购了 Fortrea 的新头寸，价值约为 46,000 美元。</p>
<h2>Fortrea 公司简介</h2>
<p>（获取免费报告）</p>
<p>Fortrea, Inc 是一家全球合同开发和制造组织（CDMO），为制药和生物技术公司提供综合解决方案。Fortrea 于 2023 年 10 月作为 Thermo Fisher Scientific 的制药服务业务的分拆公司成立，利用其科学专业知识和制造规模支持药物开发，从早期研究到商业生产。该公司的综合产品满足小分子和生物制剂项目的复杂需求，使其成为寻求加快时间表和管理成本的客户的单一来源。</p>
<p>Fortrea 的核心服务包括分析和配方开发、工艺优化、临床和商业制造以及包装服务。</p>
<h2>进一步阅读</h2>
<ul>
<li>我们更看好的五只股票比 Fortrea 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>请勿删除，立即阅读</li>
<li>该股票获得 94 分（满分 100 分）</li>
<li>自 2007 年以来首次：所有警告均已激活</li>
<li>行政命令 14330：特朗普最大的一次</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RlRSRQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RlRSRQ"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Fortrea 吗？</h2>
<p>在考虑 Fortrea 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Fortrea 并不在名单上。</p>
<p>虽然 Fortrea 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

FTRE

<p>Truist Financial 将 Fortrea (NASDAQ:FTRE) 的评级从 “持有” 上调至 “强力买入”。其他分析师的意见各不相同，瑞穗将目标价上调至 13.00 美元，巴克莱则设定在 15.00 美元。Fortrea 的股票开盘价为 17.44 美元，市值为 16.1 亿美元。该公司报告的季度每股收益为 0.12 美元，低于预期，但收入为 7.013 亿美元。Fortrea 是一家合同开发与生产组织（CDMO），专注于为制药公司提供综合解决方案，于 2023 年 10 月从赛默飞世尔科技（Thermo Fisher Scientific）分拆而来</p>

<p>Fortrea (NASDAQ:FTRE - Get Free Report) was upgraded by equities researchers at Truist Financial from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report issued on Thursday,Zacks.com reports.</p>
<div class="lb-trans"><p>Fortrea（纳斯达克代码：FTRE - 获取免费报告）在 Truist Financial 发布的一份报告中被股票研究人员从 “持有” 评级上调至 “强力买入” 评级，Zacks.com 报道。</p>
</div><p>Other research analysts have also issued research reports about the stock. Mizuho increased their target price on shares of Fortrea from $11.00 to $13.00 and gave the stock a &#34;neutral&#34; rating in a research note on Thursday, December 18th. Zacks Research lowered shares of Fortrea from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a report on Monday, October 20th. Barclays set a $15.00 target price on shares of Fortrea and gave the company an &#34;equal weight&#34; rating in a report on Monday, December 15th. Evercore ISI set a $25.00 price target on Fortrea and gave the stock an &#34;outperform&#34; rating in a research note on Tuesday. Finally, Citigroup upgraded Fortrea from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price target for the stock from $12.00 to $21.00 in a research report on Thursday, December 11th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and an average price target of $16.17.</p>
<div class="lb-trans"><p>其他研究分析师也对该股票发布了研究报告。瑞穗证券在 12 月 18 日的研究报告中将 Fortrea 的目标价格从 11.00 美元上调至 13.00 美元，并给予该股票 “中性” 评级。Zacks Research 在 10 月 20 日的报告中将 Fortrea 的评级从 “强力买入” 下调至 “持有”。巴克莱在 12 月 15 日的报告中为 Fortrea 设定了 15.00 美元的目标价格，并给予公司 “等权重” 评级。Evercore ISI 在周二为 Fortrea 设定了 25.00 美元的目标价格，并给予该股票 “跑赢大盘” 评级。最后，花旗集团在 12 月 11 日的研究报告中将 Fortrea 的评级从 “中性” 上调至 “买入”，并将该股票的目标价格从 12.00 美元上调至 21.00 美元。两位股票研究分析师给予该股票 “强力买入” 评级，三位给予 “买入” 评级，七位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “持有”，平均目标价格为 16.17 美元。</p>
</div><p><strong>Get Our Latest Research Report on Fortrea</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Fortrea 的最新研究报告</strong></p>
</div><h2>Fortrea Trading Down 0.3%</h2>
<div class="lb-trans"><h2>Fortrea 股价下跌 0.3%</h2>
</div><p>Shares of Fortrea stock opened at $17.44 on Thursday. The stock has a 50 day moving average of $14.06 and a 200 day moving average of $10.14. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.00 and a current ratio of 1.00. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of -1.55, a PEG ratio of 0.51 and a beta of 1.59. Fortrea has a fifty-two week low of $3.97 and a fifty-two week high of $19.00.</p>
<div class="lb-trans"><p>周四，Fortrea 股票开盘价为 17.44 美元。该股票的 50 日移动平均线为 14.06 美元，200 日移动平均线为 10.14 美元。公司的债务与股本比率为 1.81，速动比率为 1.00，流动比率为 1.00。该公司的市值为 16.1 亿美元，市盈率为-1.55，PEG 比率为 0.51，贝塔值为 1.59。Fortrea 的 52 周低点为 3.97 美元，52 周高点为 19.00 美元。</p>
</div><p>Fortrea (NASDAQ:FTRE - Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). The business had revenue of $701.30 million during the quarter, compared to analyst estimates of $643.43 million. Fortrea had a negative net margin of 36.77% and a positive return on equity of 5.64%. As a group, research analysts predict that Fortrea will post 0.51 earnings per share for the current year.</p>
<div class="lb-trans"><p>Fortrea（纳斯达克代码：FTRE - 获取免费报告）最后一次公布季度财报是在 11 月 5 日，报告显示该季度每股收益为 0.12 美元，低于市场共识预期的 0.16 美元（差额为 0.04 美元）。该季度的营业收入为 7.013 亿美元，而分析师预期为 6.4343 亿美元。Fortrea 的净利润率为-36.77%，股本回报率为 5.64%。作为一个整体，研究分析师预测 Fortrea 在当前年度的每股收益为 0.51 美元。</p>
</div><h2>Institutional Investors Weigh In On Fortrea</h2>
<div class="lb-trans"><h2>机构投资者对 Fortrea 的看法</h2>
</div><p>Hedge funds have recently bought and sold shares of the stock. Allworth Financial LP boosted its stake in shares of Fortrea by 6,802.4% in the 2nd quarter. Allworth Financial LP now owns 5,660 shares of the company's stock valued at $28,000 after buying an additional 5,578 shares during the period. Nisa Investment Advisors LLC raised its holdings in Fortrea by 214.3% in the third quarter. Nisa Investment Advisors LLC now owns 3,341 shares of the company's stock valued at $28,000 after acquiring an additional 2,278 shares in the last quarter. Osaic Holdings Inc. lifted its stake in Fortrea by 74.3% in the second quarter. Osaic Holdings Inc. now owns 6,844 shares of the company's stock worth $38,000 after acquiring an additional 2,918 shares during the last quarter. Tower Research Capital LLC TRC lifted its stake in Fortrea by 137.0% in the second quarter. Tower Research Capital LLC TRC now owns 8,713 shares of the company's stock worth $43,000 after acquiring an additional 5,036 shares during the last quarter. Finally, Ameritas Investment Partners Inc. acquired a new position in Fortrea during the 2nd quarter worth approximately $46,000.</p>
<div class="lb-trans"><p>对该股票的对冲基金最近进行了买入和卖出交易。Allworth Financial LP 在第二季度将其在 Fortrea 的持股比例提高了 6,802.4%。Allworth Financial LP 现在拥有 5,660 股该公司的股票，价值 28,000 美元，此前在该期间内又购买了 5,578 股。Nisa Investment Advisors LLC 在第三季度将其在 Fortrea 的持股提高了 214.3%。Nisa Investment Advisors LLC 现在拥有 3,341 股该公司的股票，价值 28,000 美元，此前在上个季度又收购了 2,278 股。Osaic Holdings Inc.在第二季度将其在 Fortrea 的持股提高了 74.3%。Osaic Holdings Inc.现在拥有 6,844 股该公司的股票，价值 38,000 美元，此前在上个季度又收购了 2,918 股。Tower Research Capital LLC TRC 在第二季度将其在 Fortrea 的持股提高了 137.0%。Tower Research Capital LLC TRC 现在拥有 8,713 股该公司的股票，价值 43,000 美元，此前在上个季度又收购了 5,036 股。最后，Ameritas Investment Partners Inc.在第二季度收购了 Fortrea 的新头寸，价值约为 46,000 美元。</p>
</div><h2>Fortrea Company Profile</h2>
<div class="lb-trans"><h2>Fortrea 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific's Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company's comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.</p>
<div class="lb-trans"><p>Fortrea, Inc 是一家全球合同开发和制造组织（CDMO），为制药和生物技术公司提供综合解决方案。Fortrea 于 2023 年 10 月作为 Thermo Fisher Scientific 的制药服务业务的分拆公司成立，利用其科学专业知识和制造规模支持药物开发，从早期研究到商业生产。该公司的综合产品满足小分子和生物制剂项目的复杂需求，使其成为寻求加快时间表和管理成本的客户的单一来源。</p>
</div><p>Fortrea's core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.</p>
<div class="lb-trans"><p>Fortrea 的核心服务包括分析和配方开发、工艺优化、临床和商业制造以及包装服务。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>进一步阅读</h2>
</div><ul>
<li>Five stocks we like better than Fortrea</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>Do not delete, read immediately</li>
<li>This stock gets a 94 out of 100</li>
<li>First Time Since 2007: All Warnings Active</li>
<li>Executive Order 14330: Trump’s Biggest Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Fortrea 更好</li>
<li>Elon 将 SpaceX 上市！$100 的首次公开募股机会！</li>
<li>请勿删除，立即阅读</li>
<li>该股票获得 94 分（满分 100 分）</li>
<li>自 2007 年以来首次：所有警告均已激活</li>
<li>行政命令 14330：特朗普最大的一次</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RlRSRQ" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=FTRE"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Fortrea Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Fortrea 吗？</h2>
</div><p>Before you consider Fortrea, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Fortrea 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortrea wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前立即购买……而 Fortrea 并不在名单上。</p>
</div><p>While Fortrea currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Fortrea 目前在分析师中获得 “持有” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Fortrea（纳斯达克股票代码：FTRE）在 Truist Financial 被上调至 “强力买入” 评级